Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases.
Hulshof EC, Lurvink RJ, Caserta N, de Hingh IHJT, van Wezel T, Böhringer S, Swen JJ, Gelderblom H, Guchelaar HJ, Deenen MJ. Hulshof EC, et al. Among authors: van wezel t. Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1925-1931. doi: 10.1016/j.ejso.2020.04.019. Epub 2020 Apr 15. Eur J Surg Oncol. 2020. PMID: 32354538
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial.
Schneider TC, de Wit D, Links TP, van Erp NP, van der Hoeven JJ, Gelderblom H, van Wezel T, van Eijk R, Morreau H, Guchelaar HJ, Kapiteijn E. Schneider TC, et al. Among authors: van eijk r, van erp np, van wezel t, van der hoeven jj. Int J Endocrinol. 2015;2015:348124. doi: 10.1155/2015/348124. Epub 2015 Jul 29. Int J Endocrinol. 2015. PMID: 26294908 Free PMC article.
Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice.
Steeghs EMP, Vink GR, Elferink MAG, Voorham QJM, Gelderblom H, Nagtegaal ID; PATH Consortium Members; Grünberg K, Ligtenberg MJL; PATH consortium members. Steeghs EMP, et al. J Clin Pathol. 2021 Oct 21;75(10):706-11. doi: 10.1136/jclinpath-2021-207865. Online ahead of print. J Clin Pathol. 2021. PMID: 34675090 Free PMC article.
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.
Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de Water B, Cornelisse CJ, Cleton-Jansen AM. Lombaerts M, et al. Among authors: van eijk r, van de water b, van wezel t. Br J Cancer. 2006 Mar 13;94(5):661-71. doi: 10.1038/sj.bjc.6602996. Br J Cancer. 2006. PMID: 16495925 Free PMC article.
High frequency of copy-neutral LOH in MUTYH-associated polyposis carcinomas.
Middeldorp A, van Puijenbroek M, Nielsen M, Corver WE, Jordanova ES, ter Haar N, Tops CM, Vasen HF, Lips EH, van Eijk R, Hes FJ, Oosting J, Wijnen J, van Wezel T, Morreau H. Middeldorp A, et al. Among authors: van puijenbroek m, van eijk r, van wezel t. J Pathol. 2008 Sep;216(1):25-31. doi: 10.1002/path.2375. J Pathol. 2008. PMID: 18506705
Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.
Middeldorp A, van Eijk R, Oosting J, Forte GI, van Puijenbroek M, van Nieuwenhuizen M, Corver WE, Ruano D, Caldes T, Wijnen J, Morreau H, van Wezel T. Middeldorp A, et al. Among authors: van puijenbroek m, van eijk r, van wezel t, van nieuwenhuizen m. Int J Cancer. 2012 Feb 15;130(4):837-46. doi: 10.1002/ijc.26093. Epub 2011 Jul 15. Int J Cancer. 2012. PMID: 21445971 Free article.
204 results